OBJECTIVE: Insomnia has high prevalence rates and is associated with significant personal
and socioeconomic burden, yet it remains largely underrecognized and inadequately …

Chronic insomnia disorder, which affects 6–10% of the population, is diagnostically
characterized by ongoing difficulties with initiating or maintaining sleep occurring at least …

Insomnia poses significant challenges to public health. It is a common condition associated
with marked impairment in function and quality of life, psychiatric and physical morbidity, and …

OBJECTIVE: Although four meta-analytic reviews support the efficacy of pharmacotherapy
and behavior therapy for the treatment of insomnia, no meta-analysis has evaluated whether …

This paper reviews the evidence regarding the efficacy of nonpharmacological treatments
for primary chronic insomnia. It is based on a review of 48 clinical trials and two meta …

Insomnia, defined by difficulty falling asleep or remaining asleep, early morning awakening
and/or non-restorative sleep, and daytime consequences, is an important public health issue …

Approximately one half of patients with insomnia have a primary psychiatric disorder such as
a depression or anxiety. Insomnia is associated with increased risk of new or recurrent …

Insomnia affects 10% to 30% of the population with a total cost of 92.5to 107.5 billion
annually. Short-term, chronic, and other types of insomnia are the three major categories …

The assessment and treatment of secondary insomnia (SI), the most common form of
insomnia, are often complicated. Establishing an accompanying disorder as causal rather …

Purpose. The diagnostic criteria and treatment of insomnia are reviewed. Summary.
Insomnia is most often described as a subjective complaint of poor sleep quality or quantity …